Genenta Science S.p.A.
$1.72▼ 1.71%($-0.03)
TickerSpark Score
61/100
▌ Mixed
60
Valuation
20
Profitability
60
Growth
84
Health
80
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNTA research report →
52-Week Range12% of range
Low
$0.55
Current
$1.72
High
$10.00
Company Overviewwww.genenta.com
About the company
Genenta Science S. p. A.
- CEO
- Pierluigi Paracchi
- IPO
- 2021
- Employees
- 13
- HQ
- Milan, MI, IT
Price Chart
-55.56% · this period
Valuation
- Market Cap
- $32.93M
- P/E
- -4.56
- P/S
- 0.00
- P/B
- 1.46
- EV/EBITDA
- -5.28
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -36.82%
- ROIC
- -21.33%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-6,272,111 · 32.63%
- EPS
- $-0.33 · 32.65%
- Op Income
- $-6,343,107
- FCF YoY
- -10.10%
Performance & Tape
- 52W High
- $10.00
- 52W Low
- $0.55
- 50D MA
- $1.22
- 200D MA
- $1.58
- Beta
- 0.75
- Avg Volume
- 1.47M
Get TickerSpark's AI analysis on GNTA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 30, 26 | Paracchi Pierluigi | other | 100,000 |
| Mar 30, 26 | Galimi Francesco | other | 20,000 |
| Mar 30, 26 | PARACCHI GIACOMOANTONIO | other | 20,000 |
| Mar 30, 26 | Sharei Armon | other | 20,000 |
| Mar 30, 26 | Mutti Miguel Maria | other | 20,000 |
| Mar 30, 26 | SLANSKY RICHARD B | other | 80,000 |
| Mar 18, 26 | PARACCHI GIACOMOANTONIO | other | 0 |
| Mar 18, 26 | PARACCHI GIACOMOANTONIO | other | 0 |
| Jun 4, 25 | Sharei Armon | other | 20,000 |
| Mar 18, 26 | Sharei Armon | other | 0 |
Coverage · GNTA
Our GNTA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on GNTA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GNTA report →Internal Compare
Similar companies
Peers in the same neighborhood.
SER▼1.04%
Serina Therapeutics, Inc.
$1.90
TELO▼2.31%
Telomir Pharmaceuticals, Inc. Common Stock
$1.27
CVM▲8.57%
CEL-SCI Corporation
$1.14
INMB▲1.19%
INmune Bio, Inc.
$1.70
MDCX▲4.08%
Medicus Pharma Ltd. Common Stock
$0.42
BRNS▼3.26%
Barinthus Biotherapeutics plc
$0.62
IPSC▲1.67%
Century Therapeutics, Inc.
$2.43
MRSN▲0.00%
Mersana Therapeutics, Inc.
$29.08